Zhou, Mengge
Liu, Jing
Hao, Yongchen
Liu, Jun
Huo, Yong
Smith, Sidney C. Jr.
Ge, Junbo
Ma, Changsheng
Han, Yaling
Fonarow, Gregg C.
Taubert, Kathryn A.
Morgan, Louise
Yang, Na
Xing, Yueyan
Zhao, Dong http://orcid.org/0000-0002-3239-3449
,
Clinical trials referenced in this document:
Documents that mention this clinical trial
The association between atrial fibrillation and in-hospital outcomes in chronic kidney disease patients with acute coronary syndrome: findings from the improving care for cardiovascular disease in China-acute coronary syndrome (CCC-ACS) project
https://doi.org/10.1186/s12872-021-02125-z
Interactions of ST-elevation myocardial infarction, age, and sex and the risk of major adverse cardiovascular events among Chinese adults: a secondary analysis of a single-centre prospective cohort
https://doi.org/10.1136/bmjopen-2021-058494
Prevalence and in-hospital outcomes of diabetes among patients with acute coronary syndrome in China: findings from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome Project
https://doi.org/10.1186/s12933-018-0793-x
Rationale and design of the Improving Care for Cardiovascular Disease in China (CCC) project: A national effort to prompt quality enhancement for acute coronary syndrome
https://doi.org/10.1016/j.ahj.2016.06.005
Association between P2Y12 inhibitor reloading and in-hospital outcomes for patients with non-ST-segment elevation acute coronary syndrome already on chronic P2Y12 receptor inhibitors therapy in China: findings from the CCC–ACS (improving care for cardiovascular disease in China-acute coronary syndrome) project
https://doi.org/10.1186/s40001-023-01025-6
Funding for this research was provided by:
American Heart Association
Chinese Society of Cardiology
Article History
Received: 14 September 2018
Accepted: 21 November 2018
First Online: 27 November 2018